Abstract
The normal function of pancreatic beta cells is vital to the control of blood glucose. Earlier research suggests that the traditional Chinese medicine Cortex Lycii Radicis may help protect pancreatic beta cells and improve insulin sensitivity. However, the specific effects and molecular mechanism of this herb have not been described. Thus, we investigated the role of Cortex Lycii Radicis in regulating the proliferation, apoptosis, and autophagy of INS-1 pancreatic beta cells. Our study revealed that Cortex Lycii Radicis extracts could promote INS-1 cell proliferation and inhibit cell apoptosis under high glucose conditions. We also evaluated the formation of autophagosomes and found that GFP-LC3 fusion protein was translocated to the autophagosome membrane. Autophagosomes increased in the group treated with Cortex Lycii Radicis compared with the no treatment control group, indicating that these extracts could promote the activation of autophagy in INS-1 cells. Our findings suggest a significant association of the Cortex Lycii Radicis extracts treatment with apoptosis and autophagy, which protects the function of pancreatic beta cells, providing evidence for the development of a new drug for diabetes treatment.
Keywords: Pancreatic beta cells, cortex Lycii Radicis, cell proliferation, cell apoptosis, autophagy, diabetes.
Current Molecular Medicine
Title:Cortex Lycii Radicis Extracts Protect Pancreatic Beta Cells Under High Glucose Conditions
Volume: 16 Issue: 6
Author(s): D. Wang and Z. Ye
Affiliation:
Keywords: Pancreatic beta cells, cortex Lycii Radicis, cell proliferation, cell apoptosis, autophagy, diabetes.
Abstract: The normal function of pancreatic beta cells is vital to the control of blood glucose. Earlier research suggests that the traditional Chinese medicine Cortex Lycii Radicis may help protect pancreatic beta cells and improve insulin sensitivity. However, the specific effects and molecular mechanism of this herb have not been described. Thus, we investigated the role of Cortex Lycii Radicis in regulating the proliferation, apoptosis, and autophagy of INS-1 pancreatic beta cells. Our study revealed that Cortex Lycii Radicis extracts could promote INS-1 cell proliferation and inhibit cell apoptosis under high glucose conditions. We also evaluated the formation of autophagosomes and found that GFP-LC3 fusion protein was translocated to the autophagosome membrane. Autophagosomes increased in the group treated with Cortex Lycii Radicis compared with the no treatment control group, indicating that these extracts could promote the activation of autophagy in INS-1 cells. Our findings suggest a significant association of the Cortex Lycii Radicis extracts treatment with apoptosis and autophagy, which protects the function of pancreatic beta cells, providing evidence for the development of a new drug for diabetes treatment.
Export Options
About this article
Cite this article as:
Wang D. and Ye Z., Cortex Lycii Radicis Extracts Protect Pancreatic Beta Cells Under High Glucose Conditions, Current Molecular Medicine 2016; 16 (6) . https://dx.doi.org/10.2174/1566524016666160523143757
DOI https://dx.doi.org/10.2174/1566524016666160523143757 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Potential of Caffeic Acid Phenethyl Ester (CAPE) in Diabetes
Current Medicinal Chemistry Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
Current Pharmaceutical Design Epidemiology and Costs of Hypertension-related Disorders
Current Pharmaceutical Design Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury
Current Molecular Medicine Targeting the Histidine Pathway in Mycobacterium tuberculosis
Current Topics in Medicinal Chemistry Vascular Protective Effects of Diabetes Medications that Mimic or Increase Glucagon-Like Peptide-1 Activity
Recent Patents on Cardiovascular Drug Discovery SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature
Current Pharmaceutical Design Patent Selections:
Recent Patents on Biomarkers Hypertension, Prehypertension and Blood Pressure Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Genomics and Natural Products: Role of Bioinformatics and Recent Patents
Recent Patents on Biotechnology Metal Catalyzed Oxidation of Alpha-Synuclein – A Role for Oligomerization in Pathology?
Current Alzheimer Research Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery Natural Products Derived from the Mediterranean Diet with Antidiabetic Activity: from Insulin Mimetic Hypoglycemic to Nutriepigenetic Modulator Compounds
Current Pharmaceutical Design Patent Perspective for Potential Antioxidant Compounds-Rutin and Quercetin
Recent Patents on Nanomedicine Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions
Current Vascular Pharmacology Assessment of the Aggregation Propensity of the β -amyloid Peptide During the Synthesis and when Free in Solution
Protein & Peptide Letters Membrane Ion Channels and Diabetes
Current Pharmaceutical Design Short-Term Effect of Hypergastrinemia Following Esomeprazole Treatment On Well-Controlled Type 2 Diabetes Mellitus: A Prospective Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Hepatocyte Growth Factor and Insulin-like Growth Factor-1 based Cellular Therapies for Oxidative Stress Injury
Current Stem Cell Research & Therapy